Study title:
Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study.
Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR.Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study.
Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR.
Type of medicine: Centrally authorised medicines
|
Therapeutic area: Nervous System Diseases
|
Brands: |
MAH holders: |
Assessment: |
Active substance: Gentian (root |
ATC code: V09A B 03 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|